Pasar al contenido principal

DESARROLLO DE ESTRATEGIAS DE INTERVENCION DIRIGIDAS A LA MICROBIOTA INTESTINAL PARA COMBATIR LA DEPRESSION

PID2022-142106OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA EN LA COMUNITAT VALENCIANA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Gut microbiome signatures associated with depression and obesity

  • Mora-Martínez, Carlos
  • Molina-Mendoza, Gara
  • Cenit, Maria Carmen
  • Medina-Rodríguez, Eva M.
  • Larroya-Garcia, Ana
  • Sánchez-Carro, Yolanda
  • González-Blanco, Leticia
  • Bobes, Julio
  • López-García, Pilar
  • Zandio-Zorrilla, Mercedes
  • Lahortiga-Ramos, Francisca
  • Gili, Margalida
  • García-Toro, Mauro
  • Barcelo, Bernardino
  • Ibarra, Olga
  • Sanz, Yolanda
[EN] Depression and obesity are highly comorbid and likely involve common risk factors and pathophysiological mechanisms, which could crosslink to gut microbiome dysfunction. Here, we performed a case-control study with a total of 105 subjects, 43 with major depressive disorder (MDD) and 62 non-depressed controls free from psychiatric comorbidities, to identify gut microbiome signatures associated with MDD and dissect its relation to body mass index (BMI) and lifestyle (diet and exercise). We performed shotgun metagenomics, followed by taxonomic and functional annotations. Using different machine learning methods, we were able to classify subjects into depressed and non-depressed controls with a balanced accuracy of 0.90 and into depressed or non-depressed and normal weight or overweight with a balanced accuracy of 0.78 based solely on taxonomic profiles. We identify novel bacterial taxa associated with depression, including reductions in Butyrivibrio hungatei and Anaerocolumna sedimenticola, and also replicate previously reported associations, such as decreased Faecalibacterium prausnitzii in patients with MDD. Functional annotation of metagenomes shows differences in pathways linked to the synthesis of fundamental nutrients, which have been associated with diet, as well as inflammation. Strikingly, we found an increase in tryptophan degradation and a decrease in queuosine synthesis pathways, both of which are directly related to a decrease in monoaminergic neurotransmitter availability. Additionally, our functional analysis shows that most of the functions that are more abundant in controls than in depressed subjects are encoded by F. prausnitzii. These findings reveal distinct microbial and functional signatures associated with depression, including taxa and pathways linked to neurotransmitter metabolism and independent of other covariates. This suggests that gut microbiome profiling could support diagnosis and the development of gut-directed depression treatments., Metagenomics; Depression; Major depressive disorder; Body mass index; Faecalibacterium prausnitzii; Overweight; Machine learning
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime

  • Medina Rodríguez, Eva M.
  • Martínez Raga, José
  • Sanz Herranz, Yolanda
Depression is a highly prevalent disorder and a leading cause of disability worldwide. It has a major impact on the affected individual and on society as a whole. Regrettably, current available treatments for this condition are insufficient in many patients. In recent years, the gut microbiome has emerged as a promising alternative target for treating and preventing depressive disorders. However, the microbes that form this ecosystem do not act alone but are part of a complicated network connecting the gut and the brain that influences our mood. Host cells that are in intimate contact with gut microbes, such as the epithelial cells forming the gut barrier and the immune cells in their vicinity, play a key role in the process. These cells continuously shape immune responses to maintain healthy communication between gut microbes and the host. In this article, we review how the interplay among epithelial cells, the immune system, and gut microbes mediates gut-brain communication to influence mood. We also discuss how advances in our knowledge of the mechanisms underlying the gut-brain axis could contribute to addressing depression. SIGNIFICANCE STATEMENT: This review does not aim to systematically describe intestinal microbes that might be beneficial or detrimental for depression. We have adopted a novel point of view by focusing on potential mechanisms underlying the crosstalk between gut microbes and their intestinal environment to control mood. These pathways could be targeted by well defined and individually tailored dietary interventions, microbes, or microbial metabolites to ameliorate depression and decrease its important social and economic impact., This work was funded by the Spanish State Research Agency (AEI, Spain) [Grant PID2022-142106OA-I00] and the Miguel Servet program from Carlos III Health Institute (ISCIII, Spain) [Grant CP22/00030], cofunded by the European Union, and supported by the EarlyCause Project of the European Union’s Horizon 2020 Research and Innovation Program [Grant 848158], the European Commission’s NextGenerationEU through the CSIC Interdisciplinary Thematic Platform (PTI+) NEURO-AGING+ (PTI-NEURO-AGING+) and Severo Ochoa grant of the National Agency for Research (AEI)- Spanish Ministry of Science and Innovation (MCIU) (Ref. CEX2021-001189-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Are conventional antidepressants enough? The gut microbiome and nanocarrier-based delivery systems as future prospects for depression treatment

  • Gastaldo Jordán, Isis
  • Villalba Pita, Claudia
  • Martínez-Raga, José
  • Sanz, Yolanda
  • Medina Rodríguez, Eva M.
Depression is the leading cause of disability worldwide and thus a major contributor to the economic burden of disease. In addition to genetic and epigenetic factors, sustained psychological stress linked to modern lifestyles (often characterized by high social expectations, elevated workload and increasing financial needs) may trigger psychiatric diseases such as depression. The effective treatment of this psychiatric condition represents one of the major challenges of our time, due to its skyrocketing increase in prevalence. While conventional antidepressants often provide low response rates and have frequent adverse effects, emerging research is revealing novel and more efficient therapeutic approaches. Notably, the bacteria that populates our intestinal tract, also known as the gut microbiota, is highly susceptible to stress and other factors associated with depression. Therefore, gut microbiota-targeting interventions based on lifestyle modifications or direct supplementation with biotherapeutic agents are being proposed as monotherapy or as adjuvants to conventional treatments. In addition, novel delivery systems, such as nanocarriers, for current antidepressants are being explored to improve drug bioavailability and therapeutic efficiency. This review summarizes the role of the gut microbiota in the pathogenesis of depression and its link with current antidepressant treatments. Furthermore, it explores how strategies like nanoparticle-based delivery systems are paving the way for the next generation of treatments., This work was funded by the Miguel Servet program from Carlos III Health Institute (ISCIII; CP22/00030), and the State Research Agency (AEI; PID2022–142106OA-I00), co-funded by the European Union, the AGROALNEXT program, supported by the Spanish Ministry of Science, Innovation and Universities (MCIU) with funding from European Union NextGenerationEU (PRTR-C17.I1) and Generalitat Valenciana (GVA) (AGROALNEXT/2022/049), and the award to IATA-CSIC as an Accredited Research Center of Excellence “Severo Ocha” (CEX2021–001189-S/MCIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiome signatures associated with depression and obesity

  • Mora-Martínez, Carlos
  • Molina-Mendoza, Gara V.
  • Cénit, M. Carmen
  • Medina Rodríguez, Eva M.
  • Larroya, Ana
  • Sánchez-Carro, Yolanda
  • González-Blanco, Leticia
  • Bobes, Julio
  • López García, Pilar
  • Zandio-Zorrilla, Mercedes
  • Lahortiga-Ramos, Francisca
  • Gili, Margalida
  • Garcia-Toro, Mauro
  • Barcelo, Bernardino
  • Ibarra, Olga
  • Sanz, Yolanda
Depression and obesity are highly comorbid and likely involve common risk factors and pathophysiological mechanisms, which could crosslink to gut microbiome dysfunction. Here, we performed a case-control study with a total of 105 subjects, 43 with major depressive disorder (MDD) and 62 non-depressed controls free from psychiatric comorbidities, to identify gut microbiome signatures associated with MDD and dissect its relation to body mass index (BMI) and lifestyle (diet and exercise). We performed shotgun metagenomics, followed by taxonomic and functional annotations. Using different machine learning methods, we were able to classify subjects into depressed and non-depressed controls with a balanced accuracy of 0.90 and into depressed or non-depressed and normal weight or overweight with a balanced accuracy of 0.78 based solely on taxonomic profiles. We identify novel bacterial taxa associated with depression, including reductions in Butyrivibrio hungatei and Anaerocolumna sedimenticola, and also replicate previously reported associations, such as decreased Faecalibacterium prausnitzii in patients with MDD. Functional annotation of metagenomes shows differences in pathways linked to the synthesis of fundamental nutrients, which have been associated with diet, as well as inflammation. Strikingly, we found an increase in tryptophan degradation and a decrease in queuosine synthesis pathways, both of which are directly related to a decrease in monoaminergic neurotransmitter availability. Additionally, our functional analysis shows that most of the functions that are more abundant in controls than in depressed subjects are encoded by F. prausnitzii. These findings reveal distinct microbial and functional signatures associated with depression, including taxa and pathways linked to neurotransmitter metabolism and independent of other covariates. This suggests that gut microbiome profiling could support diagnosis and the development of gut-directed depression treatments., This study was supported by the European Union’s Horizon 2020 research and innovation programme (EarlyCause, grant no 848158), by the European Commission—NextGeneration EU funds through CSIC Interdisciplinary Thematic Platform Neuroaging+, and by a grant from the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI), to IATA-CSIC as an Accredited Research Centre of Excellence (CEX2021-001189S/MCIN/AEI/10.13039/501100011033). The FPI contract to G.M.-M. is supported by the Spanish Ministry of Science and Innovation (PRE2018-083895). E.M.M.-R. is supported by a Miguel Servet contract from the Institute of Health Carlos III (CP22/00031), the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI) (PID2022-142106OA-I00), and co-funded by the European Union., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001189S)., Peer reviewed